Croma-Pharma
Hank Sczerba is an accomplished executive with extensive experience in commercial operations and strategic marketing within the pharmaceutical industry. Currently serving as the Executive Vice President of Commercial Operations and Global Commercial Director at Croma-Pharma since January 2019, Hank oversees global commercial activities across 13 affiliates and partnerships in 70 countries. Prior roles include Business Franchise Director for the Cardio-Metabolic Business Unit at Novartis, and various leadership positions at Eli Lilly and Company, Roche, and Kwizda Pharma, focusing on marketing strategy and commercial excellence. Hank holds an MBA in Marketing & Sales from WU Executive Academy and a Project Manager Certification from Next Level Consulting.
This person is not in any teams
This person is not in any offices
Croma-Pharma
4 followers
Croma is a global player in the minimally invasive aesthetics market and a leading European manufacturer of premium quality hyaluronic acid syringes. The company offers a comprehensive and innovative aesthetics portfolio including botulinum toxin, fillers, lifting threads and biostimulators complemented by its own skincare brand. Founded in 1976 by a pharmacist couple, Croma-Pharma GmbH is a family company headquartered in Austria where it also operates its manufacturing plant. With 550 employees, 13 subsidiaries in Europe and Brazil, two joint ventures and 60 exclusive export partners, it distributes its products in 80 markets globally, including the US, Canada, China, Australia and New Zealand. It also operates as a contract manufacturer in orthopaedics and ophthalmology. For more information please visit cromapharma.com.